- Investing Ideas
- Global Pharmaceuticals & Biotech Healthy potentially undervalued
Global Pharmaceuticals & Biotech Healthy potentially undervalued
Results
173
Companies which are potentially undervalued and in an acceptable financial position.
173 companies
Trulieve Cannabis
Market Cap: US$2.1b
Operates as a cannabis retailer in the United States.
TRLV
US$11.10
7D
17.2%
1Y
29.8%
High Tide
Market Cap: CA$297.0m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.38
7D
4.6%
1Y
-30.0%
Imeik Technology DevelopmentLtd
Market Cap: CN¥27.6b
Engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China.
300896
CN¥91.40
7D
-8.1%
1Y
-52.6%
United Therapeutics
Market Cap: US$22.0b
Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
UTHR
US$513.12
7D
0.9%
1Y
68.0%
CorMedix
Market Cap: US$639.1m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$8.20
7D
6.9%
1Y
-40.3%
Hypera
Market Cap: R$14.9b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$21.17
7D
0.9%
1Y
-10.2%
Elanco Animal Health
Market Cap: US$12.0b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$23.97
7D
1.5%
1Y
34.7%
Supernus Pharmaceuticals
Market Cap: US$2.7b
A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$45.85
7D
-5.0%
1Y
3.2%
Green Thumb Industries
Market Cap: CA$2.3b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.55
7D
3.8%
1Y
-13.2%
Hugel
Market Cap: ₩2.7t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩250,500.00
7D
-2.1%
1Y
-19.7%
Yunnan Baiyao GroupLtd
Market Cap: CN¥88.3b
Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
000538
CN¥49.50
7D
-0.6%
1Y
-14.6%
UCB
Market Cap: €42.3b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€220.00
7D
2.1%
1Y
9.5%
Vetoquinol
Market Cap: €819.4m
A veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.
VETO
€70.50
7D
0.1%
1Y
-4.7%
ANI Pharmaceuticals
Market Cap: US$1.6b
A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANIP
US$75.35
7D
-0.9%
1Y
-16.6%
Prestige Consumer Healthcare
Market Cap: US$2.4b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH
US$51.31
7D
2.5%
1Y
-21.9%
Dong-E-E-Jiao
Market Cap: CN¥30.6b
Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.
000423
CN¥48.00
7D
-6.8%
1Y
-8.4%
Bavarian Nordic
Market Cap: DKK 15.8b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 212.60
7D
13.2%
1Y
-10.6%
Diaceutics
Market Cap: UK£117.6m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.40
7D
-3.8%
1Y
1.5%
Virbac
Market Cap: €2.8b
Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.
VIRP
€329.00
7D
0%
1Y
-2.9%
Cresco Labs
Market Cap: CA$516.0m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.13
7D
4.6%
1Y
-38.9%
Tarsus Pharmaceuticals
Market Cap: US$3.2b
A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
TARS
US$72.70
7D
3.0%
1Y
28.4%
Decibel Cannabis
Market Cap: CA$72.1m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.13
7D
8.7%
1Y
-3.8%
Fennec Pharmaceuticals
Market Cap: US$395.9m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$11.29
7D
-4.6%
1Y
30.5%
Journey Medical
Market Cap: US$218.7m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$7.75
7D
20.0%
1Y
4.7%
China Resources Jiangzhong PharmaceuticalLtd
Market Cap: CN¥14.2b
Engages in the manufacture of pharmaceutical products in China.
600750
CN¥22.52
7D
-5.4%
1Y
0.9%
Duopharma Biotech Berhad
Market Cap: RM 1.2b
Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.
DPHARMA
RM 1.27
7D
3.3%
1Y
-4.5%
Amoy Diagnostics
Market Cap: CN¥7.1b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥18.41
7D
-2.8%
1Y
-25.8%
Dermapharm Holding
Market Cap: €2.0b
Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.
DMP
€39.80
7D
-0.1%
1Y
18.5%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.1b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€59.85
7D
3.9%
1Y
2.7%
China Resources Pharmaceutical Group
Market Cap: HK$29.6b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.71
7D
-3.0%
1Y
-9.9%
Madrigal Pharmaceuticals
Market Cap: US$11.9b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$516.74
7D
-1.5%
1Y
25.4%
Viatris
Market Cap: US$18.7b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$16.32
7D
0.6%
1Y
54.7%
TG Therapeutics
Market Cap: US$7.7b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$54.27
7D
10.1%
1Y
90.2%
Amphastar Pharmaceuticals
Market Cap: US$918.8m
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$21.60
7D
3.5%
1Y
-27.6%
Vanda Pharmaceuticals
Market Cap: US$319.2m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$5.28
7D
0.4%
1Y
14.5%
Protara Therapeutics
Market Cap: US$227.5m
A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.
TARA
US$3.85
7D
-3.3%
1Y
26.2%